BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 11423816)

  • 21. [Pitfalls in treatment with oral antidiabetic agents].
    Perusicová J
    Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral agent therapy in the treatment of type 2 diabetes.
    Feinglos MN; Bethel MA
    Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
    [No Abstract]   [Full Text] [Related]  

  • 24. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 25. Evolving therapeutic options for type 2 diabetes mellitus: an overview.
    Guthrie RM
    Postgrad Med; 2012 Nov; 124(6):82-9. PubMed ID: 23322141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of noninsulin antidiabetic medications in hospitalized patients.
    Kopecky C
    Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 29. [Oral antidiabetic drugs].
    Tauber JP
    Rev Prat; 1999 Jan; 49(1):46-50. PubMed ID: 9926716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 31. Use oral hypoglycemics with caution..
    Jackson JE; Bressler R
    Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057
    [No Abstract]   [Full Text] [Related]  

  • 32. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
    Pernet A; Bäbler M; Ganz K
    Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
    [No Abstract]   [Full Text] [Related]  

  • 33. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M; Langhan T; Prosser J; Hoffman R
    Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract]   [Full Text] [Related]  

  • 35. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of diabetes mellitus with oral hypoglycemic agents].
    Takamoto I; Kadowaki T
    Nihon Rinsho; 2011 Mar; 69(3):563-72. PubMed ID: 21400857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral agents in the management of type 2 diabetes mellitus.
    Luna B; Feinglos MN
    Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M
    Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    McCormick M; Quinn L
    J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.